Medicure Inc.
MPH.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.70% | -9.53% | 12.98% | 1.31% | -15.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.70% | -9.53% | 12.98% | 1.31% | -15.39% |
| Cost of Revenue | 44.52% | 19.39% | -11.86% | 69.97% | 20.37% |
| Gross Profit | 15.08% | -26.14% | 41.41% | -24.38% | -30.80% |
| SG&A Expenses | 4.80% | -13.97% | -4.60% | 2.22% | -1.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.98% | -3.07% | -6.79% | 26.36% | 8.87% |
| Operating Income | 38.16% | -148.22% | 69.57% | -1,351.18% | -435.66% |
| Income Before Tax | 34.96% | -851.81% | 73.52% | 762.20% | -440.63% |
| Income Tax Expenses | -47.89% | 15.22% | 384.72% | 28.85% | 63.75% |
| Earnings from Continuing Operations | 36.13% | -1,379.37% | 65.28% | 696.49% | -572.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.13% | -1,379.37% | 65.28% | 696.49% | -572.33% |
| EBIT | 38.16% | -148.22% | 69.57% | -1,351.18% | -435.66% |
| EBITDA | 70.64% | -133.41% | 81.22% | -202.50% | -162.31% |
| EPS Basic | 36.15% | -1,386.11% | 65.23% | 696.67% | -573.33% |
| Normalized Basic EPS | 34.92% | -204.55% | 73.53% | -1,629.41% | -440.85% |
| EPS Diluted | 34.09% | -1,455.56% | 65.23% | 696.67% | -688.59% |
| Normalized Diluted EPS | 34.92% | -204.55% | 73.53% | -1,777.42% | -443.26% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | -0.57% | 0.00% | -10.96% | -0.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |